207 related articles for article (PubMed ID: 8623487)
1. Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study.
Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Sehgal SN; Nakhleh RE; Gruessner RW
Transplant Proc; 1996 Apr; 28(2):981-3. PubMed ID: 8623487
[No Abstract] [Full Text] [Related]
2. FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model.
Troppmann C; Papalois BE; Gruessner AC; Nakhleh RE; Gruessner RW
Transplant Proc; 1997; 29(1-2):914-5. PubMed ID: 9123585
[No Abstract] [Full Text] [Related]
3. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
[No Abstract] [Full Text] [Related]
4. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
[No Abstract] [Full Text] [Related]
5. Six- to eight-month survival of discordant pig islet xenografts documented by differential species, insulin, and C-peptide in animals given short-term immunosuppression.
Henretta J; McFadden T; Pittman K; Thomas J; Thomas F
Transplant Proc; 1994 Jun; 26(3):1138-9. PubMed ID: 8029861
[No Abstract] [Full Text] [Related]
6. Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting.
Hisanaga M; Nakajima Y; Yabuuchi H; Nakano H
Transplant Proc; 1992 Jun; 24(3):1043-4. PubMed ID: 1376513
[No Abstract] [Full Text] [Related]
7. Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts.
Henretta J; Pittman K; McFadden T; Thomas J; Thomas F
Transplant Proc; 1993 Feb; 25(1 Pt 1):412-3. PubMed ID: 8438358
[No Abstract] [Full Text] [Related]
8. Fish-to-mouse islet xenograft survival is markedly prolonged by 15-deoxyspergualin.
Wright JR; Kearns H
Transplant Proc; 1995 Feb; 27(1):294-5. PubMed ID: 7879009
[No Abstract] [Full Text] [Related]
9. Local immunologic factors determine the occurrence of primary nonfunction of islet xenografts.
Marquet RL; Bouwman E; Bonthuis F; Wolvekamp MC; Kouwenhoven E; van Rooijen N; Scheringa M; Ijzermans JN
Transplant Proc; 1994 Apr; 26(2):766-7. PubMed ID: 8171654
[No Abstract] [Full Text] [Related]
10. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts.
Thomas F; Pittman K; Ljung T; Cekada E
Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045
[TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical experience with xenoislet transplantation.
Groth CG; Tibell A; Wennberg L; Korsgren O
Transplant Proc; 1996 Dec; 28(6):3515. PubMed ID: 8962366
[No Abstract] [Full Text] [Related]
12. Effect of rapamycin on islet and skin xenograft survival.
Bobbio SA; Porter JG; Monaco AP
Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
[No Abstract] [Full Text] [Related]
13. Significance of low doses of 15-deoxyspergualin in agarose-microencapsulated discordant islet xenotransplantation.
Aomatsu Y; Nakajima Y; Iwata H; Amemiya H; Kanehiro H; Hisanaga M; Yoshimura A; Kido K; Taki J; Horikawa M
Transplant Proc; 1995 Feb; 27(1):292-3. PubMed ID: 7879008
[No Abstract] [Full Text] [Related]
14. Prevention of primary nonfunction of xenograft islets.
Pittman K; Henretta J; McFadden T; Thomas J; Thomas FT
Transplant Proc; 1994 Jun; 26(3):1141-2. PubMed ID: 8029862
[No Abstract] [Full Text] [Related]
15. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats.
Sung RS; Fiedor PS; Yaron I; Zakheim AR; Quadracci KM; Goodman ER; Hardy MA
Transplant Proc; 1996 Apr; 28(2):839. PubMed ID: 8623427
[No Abstract] [Full Text] [Related]
16. Immunohistological study of islet xenograft rejection in immunosuppressed recipients.
Andereggen E; Bühler L; Fournier B; Deng S; Bubloz C; Morel P
Transplant Proc; 1996 Apr; 28(2):826-8. PubMed ID: 8623420
[No Abstract] [Full Text] [Related]
17. Major impact of engraftment site on early functional outcome of discordant xenoislet grafts from a large animal donor.
Troppmann C; Papalois BE; Gruessner AC; Nakhleh RE; Gruessner RW
Transplant Proc; 1997 Jun; 29(4):2107-8. PubMed ID: 9193548
[No Abstract] [Full Text] [Related]
18. Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts.
Lupi R; Marchetti P; Coppelli A; Giannarelli R; Petraglia F; Luisi S; Del Guerra S; Tellini C; Florio P; Genazzani A; Viacava P; Navalesi R
Transplant Proc; 1998 Aug; 30(5):2481-3. PubMed ID: 9723547
[No Abstract] [Full Text] [Related]
19. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Wennberg L; Song Z; Zhang J; Bennet W; Nava S; Bari S; Sundberg B; Korsgren O; Groth CG
Transplant Proc; 2000 Aug; 32(5):1061. PubMed ID: 10936353
[No Abstract] [Full Text] [Related]
20. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
